Healthline

All About Kesimpta Injection

Kesimpta is a prescription medication used to treat clinically isolated syndrome and specific types of multiple sclerosis. Kesimpta comes as a liquid solution for injection under your skin. Common ...
Healthline

All About Kesimpta’s Dosage

Kesimpta (ofatumumab) is a prescription drug used to treat clinically isolated syndrome (CIS) and multiple sclerosis (MS) in adults. The drug comes as a liquid solution for injection under the skin.
Nasdaq

FDA approves Novartis Kesimpta® (ofatumumab), the first and only self-administered, targeted B-cell therapy for patients with relapsing multiple sclerosis

The digital press release with multimedia content can be accessed here: Basel, August 20, 2020 — Novartis today announced that the US Food and Drug Administration (FDA) has approved Kesimpta® ...
Morningstar

New Novartis data further support benefits of Kesimpta® in relapsing MS following switch from oral disease modifying therapies

ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS) following switch to Kesimpta after ...
Seeking Alpha

Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment-naïve people with relapsing multiple sclerosis

Continuous Kesimpta® treatment for up to six years showed sustained efficacy in recently diagnosed (≤3 years) treatment-naïve people living with relapsing multiple sclerosis (RMS) in an analysis of ...
FiercePharma

Novartis 'not leaving any stone unturned' for Kesimpta, Leqvio as Entresto, Cosentyx drive growth

At Novartis these days, immunology therapy Cosentyx and heart drug Entresto are without a doubt the major growth drivers. But as the company continues its search for new star meds, it’s betting on ...